Oramed Pharmaceuticals Inc. is a clinical-stage pharmaceutical enterprise dedicated to developing innovative oral drug delivery systems, shifting traditional injectable peptide and protein therapeutics into convenient oral capsule formats. Its proprietary POD (Protein Oral Delivery) technology is designed to protect active pharmaceutical ingredients from harsh gastrointestinal environments, enabling oral administration for treatments such as oral insulin and other biologic therapies currently restricted to injections.